Next-Generation Sequencing Eric Jorgenson Epidemiology 217 2/28/12.

Next-Generation Sequencing

Eric Jorgenson

Epidemiology 217

2/28/12

Outline

• Overview of Sequencing

• Example Next Generation Sequencing Study: Whole Genome, Exome, Families (IBD), Cancer

• PTC Taste Sensitivity

http://www.bloomberg.com/video/84364498/



http://www.bloomberg.com/news/2012-01-17/search-genome-as-tennis-thrice-weekly-no-barrier-to-decoded-dna.html

http://www.bloomberg.com/news/2012-02-15/harvard-mapping-my-dna-turns-scary-as-threatening-gene-emerges.html

Links to videos and articles

QuickTime™ and a decompressor

are needed to see this picture.

Huntington’s Disease Testing

Almqvist AJHG 1999

Number of Genetic Markers for Genetic StudiesGenome-wide Linkage Studies

300-400 Microsatellite Markers

Genome-wide Association Studies

100,000-2,500,000 SNPs

Exome Sequencing Studies

30,000,000 Basepairs

Gene-based Studies

22,000 Genes

Whole Genome Sequencing Studies

3,200,000,000 Basepairs

Variant detection through next generation sequencing



Meyerson et al. NRG 2010

ANNOVAR: Using Annotation to Narrow the Search Space

openbioinformatics.org/annovar

Outline




Sequencing of a Single Individual with Family Data

Lupski et al. NEJM 2010



CMT Subtypes: Many Genes



Phenotypes in Unsequenced Family Members



SNP Distribution in Proband



The First 8 Human Genomes



Nonsynonymous SNPs in Known Disease Genes



Family Pedigree



Putative Causal Variant at a Conserved Amino Acid



Exome Sequencing Identifies a Tibetan Adaptation

Yi et al. Science 2010



Family Sequencing for Rare Diseases

Roach et al. Science 2010



Sequence Data Improves Identity By Descent Resolution



Su and Jorgenson under review

Cancer: Tumor vs. Normal

Lee et al. Nature 2010





Molenaar et al. Nature 2012

Nonsynonymous Somatic Mutations in Neuroblastoma



Molenaar et al. Nature 2012

Mutation count associated with age, stage, and survival

Outline




Distribution of PTC Phenotype

PTC Score

Nu

mb

er

of S

ubje

cts

TAS2R38 Receptor Structure

Kim et al. J Dent Res 2004

3 SNPs Form 3 Haplotypes

P A V

A V I

A A V

Taster

Non-taster

Rare

PTC Phenotype by TAS2R38 Diplotype

PTC Score

Nu

mb

er

of S

ubje

cts

Outliers After Adjusting for TAS2R38 Diplotype

PTC Score

Nu

mb

er

of S

ubje

cts

Unusual PTC Phenotypes (AVI Homozygotes in Green)

11

8

108 9 93 912

9

Unusual PTC Phenotypes (AVI Homozygotes in Green)

14 10 9 11410 2

11

11

10 Genomes, 5 Hard Drives

Summary of Variation Utah

Sample 1 Sample 2 Sample 3 Sample 4 Sample 5Gender Female Female Male Female FemaleTotal Sequence (Gb) 214 220 218 243 219Percent fully called 0.95 0.96 0.96 0.97 0.96Coverage (X fold) 53 55 53 63 54

SNPs 3,270,920 3,269,487 3,278,557 3,355,266 3,341,154Insertions 184,763 190,633 197,830 210,805 206,120Deletions 195,419 200,495 208,031 221,532 216,578

Synonymous SNPs 9,666 9,547 9,808 10,004 9,981Missense SNPs 9,253 9,135 9,350 9,486 9,581Nonsense SNPs 90 97 82 88 92Frameshift Insertions 103 102 97 112 127Frameshift Deletions 99 101 91 108 116

Novel SNPs 0.04 0.04 0.04 0.04 0.04Novel Insertions 0.18 0.18 0.19 0.20 0.19Novel Deltions 0.22 0.22 0.23 0.23 0.23

Quality Control:99.8% Concordance

Sample 1 Genotyping

Sequencing Homozygous Reference

Heterozygous Homozygous Variant

Homozygous Reference

479,773 429 422

Heterozygous426 234,156 293

Homozygous Variant

65 168 172,479

Variant Distribution in Utah

Using Relatedness

11

8

108 9 93 912

9

Identity By Descent

Chromosome Gene Start Stop1 ANXA9 150958836 1509588361 S100A7A 153391729 1533917295 PCDHB5 140517174 1405171746 HLA-A 29910604 299106046 HLA-A 29912856 299128567 ZAN 100371474 1003714749 BAG1 33264540 3326454010 WDR96 105957714 10595771410 GSTO1 106027059 10602705911 MUC6 1018116 101811611 OR4C45 48367311 4836731111 TRIM64 89701844 8970184412 NANOGNB 7917936 791793614 ZBTB1 64988830 6498883019 PSG3 43243238 43243238X HDHD1 6975782 6975782X ZCCHC16 111698036 111698036X SAGE1 134994005 134994005X GPR101 136112707 136112707

Nonsynonymous Variants

How can whole genome sequence influence treatment?• Identify Genes with Protein Altering

Mutations

• Determine Variation in Specific Genes

Genes with Protein Altering Variants

0 1000 2000 3000 4000 5000 6000 7000 8000 9000

Sample 1

Sample 2

Sample 3

Sample 4

Sample 5

Sample 6

Sample 7

Sample 8

Sample 9

Sample 10

KnownNovel

ABO Blood Group

Determination of ABO Type

Population Genotype Blood Type261 796 803

UtahSample 1 -/- G/G C/C OO OSample 2 -/- G/G C/C OO OSample 3 -/- G/G C/C OO OSample 4 C/- G/G C/C AO ASample 5 C/- G/G C/C AO A

Costa RicaSample 6 C/- G/G C/C AO ASample 7 C/- G/G C/C AO ASample 8 -/- G/G C/C OO OSample 9 C/? G/G C/C AO or AA ASample 10 -/- G/G C/C OO O

Position

Appendix: Study Design Considerations in Sequencing

• Extreme Sampling

• Families

Sampling from the Extremes of a Quantitative Distribution



Su and Jorgenson under revision

Relative Power of Sampling from Various Phenotype Deciles



Su and Jorgenson under revision



Roach et al. Science 2010

Families can reduce error rates

Next-Generation Sequencing Eric Jorgenson Epidemiology 217 2/28/12.

Documents

Transcript of Next-Generation Sequencing Eric Jorgenson Epidemiology 217 2/28/12.